Welgene Biotech Co.,Ltd. Stock Price

TPEX:6661 Community·NT$433.5m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6661 Share Price Performance

NT$18.60

-4.90 (-20.85%)

NT$18.60

-4.90 (-20.85%)

NT$18.60

Tue, 3 Mar 26

Share Pricen/a

6661 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Adequate balance sheet and fair value.

2 Risks

2 Rewards

View Full Analysis

Welgene Biotech Co.,Ltd. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 0.07
: 41.79%
: 0.45%
: 55.5%

View Full Analysis

About 6661

Founded: 2003
Employees: n/a
CEO: Yi Xing Lin
WebsiteView website: www.welgene.com.tw

Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.